CARTHIEL advised the sellers in Perpetua Medical AB (publ)'s purchase of a majority holding in Spirotronic AB

Spirotronic is an innovative medical technology company with cutting-edge expertise in anesthesia and intensive care. The company offers consulting services in this area. In recent years, Spirotronic has also developed several components intended to be integrated into anesthesia equipment and ventilators. Recently, Spirotronic received a breakthrough order in the important Indian market for one of its developed components. The focus of the component business will be on sales and marketing initiatives in Europe and Asia, as well as continued product development of new components.

Perpetua Medical is an acquirer of profitable and product-oriented companies within the healthcare sector. The company's assessment is that a decentralized ownership model, where operations and decision-making occur in independent subsidiaries, creates the best conditions for value creation. The company's name, Perpetua (the Latin word for eternal) Medical reflects the strategy of acquiring healthcare companies to own them without any specified time horizon.

Perpetua Medical AB (publ) is traded on Nasdaq First North Stockholm (ticker PERP B).

The sellers were represented by Advokatfirman CARTHIEL AB through Gustaf Cardelius.